Photodynamic Therapy for Basal Cell Carcinoma: The Clinical Context for Future Research Priorities
Photodynamic therapy (PDT) is an established treatment option for low-risk basal cell carcinoma (BCC). BCC is the most common human cancer and also a convenient cancer in which to study PDT treatment. This review clarifies challenges to researchers evident from the clinical use of PDT in BCC treatme...
Main Authors: | Nicholas J. Collier, Lesley E. Rhodes |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/22/5398 |
Similar Items
-
Systematic Review and Meta-Analysis of In Vitro Anti-Human Cancer Experiments Investigating the Use of 5-Aminolevulinic Acid (5-ALA) for Photodynamic Therapy
by: Yo Shinoda, et al.
Published: (2021-03-01) -
Regression Analysis of Protoporphyrin IX Measurements Obtained During Dermatological Photodynamic Therapy
by: Jessica Tyrrell, et al.
Published: (2019-01-01) -
5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy
by: Richard Howley, et al.
Published: (2023-04-01) -
Photodynamic Effects with 5-Aminolevulinic Acid on Cytokines and Exosomes in Human Peripheral Blood Mononuclear Cells
by: Kristian Espeland, et al.
Published: (2022-01-01) -
Photodynamic Effects with 5-Aminolevulinic Acid on Cytokines and Exosomes in Human Peripheral Blood Mononuclear Cells from Patients with Crohn’s Disease
by: Kristian Espeland, et al.
Published: (2023-02-01)